Modulation of HL-A antigens by anti-HLA antiserum: effects on the cytotoxicity assay and mixed leukocyte reaction.
Modulation of human leukocyte antigen (HLA) was attempted by treating leukocytes with specific anti-HLA antiserum or by their passage through columns coated with anti-HLA or a double layer of HLA-anti-HLA. The modulated cells were resistant to the cytotoxic effects of the anti-HLA, and they were poor stimulators and good responders to allogeneic cells in the unidirectional mixed leukocyte reaction. Modulated cells regained their HLA 16 hr after modulation if kept in cell suspension alone. The proliferative responses of modulated cells to mitogens were as good as non-modulated cells, indicating that modulation was probably not caused by depletion of lymphoid cells. Supernatants of modulated cells that were incubated overnight or preformed HLA-anti-HLA complexes were capable of suppressing and enhancing the MLR of specific cells depending on the dose used. The similarities of modulation of HLA to other lymphocyte receptors and the limitation of application of the modulation phenomenon to transplantation of allogeneic cells are discussed.
D000918:Antibody Specificity; D000936:Antigen-Antibody Complex; D002469:Cell Separation; D002474:Cell-Free System; D002478:Cells, Cultured; D003601:Cytotoxicity Tests, Immunologic; D005898:Glass; D006680:HLA Antigens; D006648:Histocompatibility; D006649:Histocompatibility Antigens; D006801:Humans; D007111:Immunity, Cellular; D007518:Isoantibodies; D037102:Lectins; D007962:Leukocytes / Q000276:immunology; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000936:Antigen-Antibody Complex; D006680:HLA Antigens; D006649:Histocompatibility Antigens; D007518:Isoantibodies; D037102:Lectins; D014316:Tritium; D013936:Thymidine